Uveal melanoma
|
0.800 |
CausalMutation
|
disease |
CGI |
|
|
|
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
HPO |
|
|
|
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Uveal melanoma
|
0.800 |
SomaticCausalMutation
|
disease |
ORPHANET |
These findings implicate loss of BAP1 in uveal melanoma metastasis and suggest that the BAP1 pathway may be a valuable therapeutic target.
|
21051595 |
2010 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
These results identify a BAP1-related cancer syndrome that is characterized by mesothelioma and uveal melanoma.
|
21874000 |
2011 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
CTD_human |
These results identify a BAP1-related cancer syndrome that is characterized by mesothelioma and uveal melanoma.
|
21874000 |
2011 |
Uveal melanoma
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
The results indicate that BAP1 is the candidate gene in only a small subset of hereditary UM, suggesting the contribution of other candidate genes.
|
21941004 |
2011 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
The results indicate that BAP1 is the candidate gene in only a small subset of hereditary UM, suggesting the contribution of other candidate genes.
|
21941004 |
2011 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
The purpose of this study was to identify therapeutic agents that reverse the phenotypic effects of BAP1 loss in UM.
|
22038994 |
2012 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
De-ubiquitinating enzyme BAP1 is mutated in a hereditary cancer syndrome with increased risk of mesothelioma and uveal melanoma.
|
22878500 |
2012 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Somatic BAP1 mutations are seen in cutaneous melanocytic tumours (epithelioid atypical Spitz tumours and melanoma), uveal melanoma, mesothelioma, clear cell renal cell carcinoma, and other tumours.
|
23277170 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Screening of BAP1 germline mutations in families predisposed for UM may be used to identify individuals at increased risk of disease.
|
23341325 |
2013 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
|
23915344 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Whole-exome sequencing identified a BAP1 splice mutation located at c.581-2A>G, which leads to a premature truncation of BAP1 in an individual with uveal melanoma.
|
23977234 |
2013 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
However, BAP1 germline mutations have been identified in rare hereditary tumour syndromes, including cases with UM.
|
24187051 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The results of this study confirm the association between germline BAP1 mutation and predisposition to UM, mesothelioma, CM and RCC.
|
24243779 |
2014 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Mutations in the tumor suppressor BAP1 enhance the metastatic potential of uveal melanoma and predispose to cutaneous/ocular melanoma, atypical melanocytic tumors, and other internal malignancies (COMMON syndrome).
|
24258989 |
2014 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Furthermore, our analysis indicates that loss of BAP1 may be particularly involved in the progression of uveal melanoma to an aggressive, metastatic phenotype.
|
24633195 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Both UM and CM have been shown to harbor germline mutation of BAP1.
|
24697775 |
2014 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
|
24970262 |
2014 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
BEFREE |
Loss of BAP1 expression associated well with all of the methods currently used for prognostication and was itself predictive of death due to metastasis in uveal melanoma after enucleation, thereby emphasising the importance of further research on the role of BAP1 in uveal melanoma.
|
25147369 |
2014 |
Uveal melanoma
|
0.800 |
Biomarker
|
disease |
CTD_human |
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
|
25231345 |
2015 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
BAP1 loss-of-function mutations were found in three UMs.
|
25361747 |
2015 |
Uveal melanoma
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
We investigated BAP1 and BRAFV600E expression in 193 sporadic melanocytic lesions (11 dermal nevi, 20 congenital nevi, 40 primary and nondesmoplastic melanomas, 40 desmoplastic melanomas, 23 metastatic melanomas, 17 Spitz nevi, 19 atypical Spitz nevi, 8 atypical Spitz tumors, 14 proliferative nodules arising in congenital nevi, 1 nevus during pregnancy) and 30 melanocytic lesions from 3 patients with family history of uveal melanoma and BAP1 germline mutation.
|
25479927 |
2015 |
Uveal melanoma
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
BAP1 mutations are frequently found in UM and are associated with a poor prognosis.
|
25582751 |
2015 |